These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 17459610)

  • 21. Dose to bone marrow using IMRT techniques in prostate cancer patients.
    Gershkevitsh E; Clark CH; Staffurth J; Dearnaley DP; Trott KR
    Strahlenther Onkol; 2005 Mar; 181(3):172-8. PubMed ID: 15756521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of prostate and seminal vesicle interfraction variation during IMRT.
    Frank SJ; Dong L; Kudchadker RJ; De Crevoisier R; Lee AK; Cheung R; Choi S; O'Daniel J; Tucker SL; Wang H; Kuban DA
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):813-20. PubMed ID: 18207664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adequate margins for random setup uncertainties in head-and-neck IMRT.
    Astreinidou E; Bel A; Raaijmakers CP; Terhaard CH; Lagendijk JJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):938-44. PubMed ID: 15708278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
    Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental testicular irradiation from prostate IMRT: it all adds up.
    King CR; Maxim PG; Hsu A; Kapp DS
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):484-9. PubMed ID: 19733013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.
    Ganswindt U; Paulsen F; Corvin S; Hundt I; Alber M; Frey B; Stenzl A; Bares R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):347-55. PubMed ID: 17236960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of dose compensation in image-guided radiotherapy of prostate cancer.
    Wu Q; Liang J; Yan D
    Phys Med Biol; 2006 Mar; 51(6):1405-19. PubMed ID: 16510952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
    Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
    Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
    Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric influences of rotational setup errors on head and neck carcinoma intensity-modulated radiation therapy treatments.
    Fu W; Yang Y; Yue NJ; Heron DE; Saiful Huq M
    Med Dosim; 2013; 38(2):125-32. PubMed ID: 23266161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer.
    Vaarkamp J; Malde R; Dixit S; Hamilton CS
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):310-7. PubMed ID: 19624299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.
    Chung HT; Xia P; Chan LW; Park-Somers E; Roach M
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):53-60. PubMed ID: 18501530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An imrt technique to increase therapeutic ratio of breast irradiation in patients with early-stage left breast cancer: limiting second malignancies.
    Ahmed RS; De Los Santos JF; Fiveash JB; Keene KS; Popple RA
    Med Dosim; 2008; 33(1):71-7. PubMed ID: 18262126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer.
    Price RA; Hannoun-Levi JM; Horwitz E; Buyyounouski M; Ruth KJ; Ma CM; Pollack A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):583-92. PubMed ID: 16966000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of IMRT to cover pelvic nodes while escalating the dose to the prostate gland: dosimetric data on 35 consecutive patients.
    Bayouth JE; Pena J; Culp L; Brack C; Sanguineti G
    Med Dosim; 2008; 33(3):180-90. PubMed ID: 18674682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
    Eminowicz G; Dean C; Shoffren O; Macdougall N; Wells P; Muirhead R
    Br J Radiol; 2014 May; 87(1037):20130696. PubMed ID: 24646126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.